The merger creates a group with revenues of $136.5mln in 2018 and re-unites the Lojuxta cholesterol treatment under one roof.
Amryt Pharma co-founder welcomes 'transformational' Aegerion acquisition
Quick facts: Open Orphan Plc
Price: 6.7 GBX
Market Cap: £17.06 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Open Orphan Plc named herein, including the promotion by the Company of Open Orphan Plc in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE